ID

14105

Beskrivning

Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01507311

Länk

https://clinicaltrials.gov/show/NCT01507311

Nyckelord

Versioner (1)
  1. 29/03/2016 29/03/2016 -
Uppladdad den

29 mars 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Diabetes NCT01507311

Engelsk

Eligibility Diabetes NCT01507311

1 Formulär  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01507311
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed with type 2 diabetes, either newly diagnosed with at least two months of diet treatment, or in current oha (oral hypoglycaemic agent) treatment with stable dose for at least six months
Beskrivning

Type 2 diabetes and treatment

Datatyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0011878
UMLS CUI [3]
C0359086
bmi (body mass index) between 24 and 35 kg/m^2 (both inclusive)
Beskrivning

BMI

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
fasting plasma glucose between 6 and 15 mmol/l (both inclusive)
Beskrivning

Fasting plasma glucose

Datatyp

boolean

Alias
UMLS CUI [1]
C0583513
anti-gad (glutamic acid decarboxylase) negative
Beskrivning

Anti-gad

Datatyp

boolean

Alias
UMLS CUI [1]
C1167898
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to trial product or related products
Beskrivning

Allergy to trial product

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3854006
receipt of any investigational drug within three months prior to this trial
Beskrivning

Experimental drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0304229
recurrent severe hypoglycaemia as judged by the investigator
Beskrivning

Recurrent severe hypoglycaemia

Datatyp

boolean

Alias
UMLS CUI [1]
C0342316
cardiac disease or any clinically significant abnormal ecg (electrocardiogram)
Beskrivning

Cardiac disease or ECG

Datatyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0013798
use of any drug (except oral hypoglycaemic agents (ohas)) which in the investigator's opinion could interfere
Beskrivning

Pharmacotherapy and drug interactions

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0687133
with the blood glucose level (i.e., insulin, systemic corticosteroids, thiazides)
Beskrivning

Medication interferring with blood glucose level

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0392201
UMLS CUI [1,2]
C0013216
UMLS CUI [1,3]
C0687133
liver or renal disease
Beskrivning

Liver or renal disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0022658
Tillbaka till toppen

Similar models

Eligibility Diabetes NCT01507311

1 Formulär
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01507311
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes and treatment
Item
diagnosed with type 2 diabetes, either newly diagnosed with at least two months of diet treatment, or in current oha (oral hypoglycaemic agent) treatment with stable dose for at least six months
boolean
C0011860 (UMLS CUI [1])
C0011878 (UMLS CUI [2])
C0359086 (UMLS CUI [3])
BMI
Item
bmi (body mass index) between 24 and 35 kg/m^2 (both inclusive)
boolean
C1305855 (UMLS CUI [1])
Fasting plasma glucose
Item
fasting plasma glucose between 6 and 15 mmol/l (both inclusive)
boolean
C0583513 (UMLS CUI [1])
Anti-gad
Item
anti-gad (glutamic acid decarboxylase) negative
boolean
C1167898 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Experimental drugs
Item
receipt of any investigational drug within three months prior to this trial
boolean
C0304229 (UMLS CUI [1])
Recurrent severe hypoglycaemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0342316 (UMLS CUI [1])
Cardiac disease or ECG
Item
cardiac disease or any clinically significant abnormal ecg (electrocardiogram)
boolean
C0018799 (UMLS CUI [1])
C0013798 (UMLS CUI [2])
Pharmacotherapy and drug interactions
Item
use of any drug (except oral hypoglycaemic agents (ohas)) which in the investigator's opinion could interfere
boolean
C0013216 (UMLS CUI [1,1])
C0687133 (UMLS CUI [1,2])
Medication interferring with blood glucose level
Item
with the blood glucose level (i.e., insulin, systemic corticosteroids, thiazides)
boolean
C0392201 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
C0687133 (UMLS CUI [1,3])
Liver or renal disease
Item
liver or renal disease
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial